Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HID1 antisense RNA 1 (HID1-AS1) is a long non-coding RNA (lncRNA) transcribed from the DNA strand opposite to the HID1 gene. While the specific function of HID1-AS1 has not been well characterized in the literature, antisense lncRNAs are generally known to regulate the expression of their corresponding sense genes via interaction at the transcriptional or posttranscriptional level. Antisense lncRNAs play roles in recruiting chromatin-modifying enzymes to specific gene loci, forming RNA duplexes with their sense mRNAs to regulate stability, and acting in both oncogenic and tumor-suppressor capacities depending on cellular context. There is currently no direct evidence in public databases or the scientific literature that HID1-AS1 is a well-established therapeutic target or is directly implicated in human disease, and there are no known drugs, biomarkers, mechanisms of action, or safety concerns documented for this specific molecule[4]. Note: HID1-AS1 should not be confused with HID1, which refers to either a plant non-coding RNA with a role in photomorphogenesis[1][3] or a protein involved in neurosecretion in nematodes and mammals[5]. No direct data about the function or therapeutic relevance of HID1-AS1 in human tissues was found in the supplied literature or leading biomedical archives. In summary, it is a canonical antisense lncRNA with presumed regulatory function but lacking established disease or pharmacological relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HID1 antisense RNA 1 (HID1-AS1).